Professor of Cardiovascular Medicine
- Honorary Consultant Cardiologist
- Head of the Division of Cardiovascular Medicine
- Director, University of Oxford Centre Clinical Magnetic Resonance Research (OCMR)
Phenotyping of cardiovascular and multiorgan disease with advanced non-invasive imaging methods
Stefan Neubauer is a Professor of Cardiovascular Medicine, Head of the Division of Cardiovascular Medicine and Director of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, John Radcliffe Hospital, United Kingdom.
Professor Neubauer’s work over the past 35 years has been devoted to the development and application of Cardiovascular Magnetic Resonance (CMR) imaging and spectroscopy, and, in recent years, also to the development of novel liver and multiorgan MR imaging as well as novel coronary CT imaging.
He has attracted over £180M in research funding, has published >580 original research articles and currently leads a group of ~60 co-workers. He has supervised over 50 PhD/MD students, who have won >25 young investigator awards.
Editorial positions and contributions to scientific bodies include:
- Society for Cardiovascular Magnetic Resonance (President 2006-2007)
- Chairman of the British Society of Cardiovascular Magnetic Resonance (2008-2010)
- International Associate Editor of the European Heart Journal (2010-2020)
- Associate Editor of the Journal of Cardiovascular Magnetic Resonance.
Awards and Honours include:
- American Heart Association Paul Dudley White International Lectureship Award 2005
- British Cardiovascular Society Thomas Lewis Lecture 2008
- National Institute for Health Research Senior Investigator Award 2010
- the European Magnetic Resonance Award 2010
- the SCMR Gold Medal 2013
Professor Neubauer is a fellow of the UK Academy of Medical Sciences. He has been the leader of the Imaging Theme for the Oxford NIHR Biomedical Research Centre since 2017. He is also a founder, and was (2012-2019) CMO of Perspectum, a biomedical imaging biotech company, and is a founder and NED of Caristo Diagnostics (since 2018), a cardiac CT spinout company.
Characterizing the hypertensive cardiovascular phenotype in the UK Biobank.
Elghazaly H. et al, (2023), European heart journal. Cardiovascular Imaging
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Zheng B. et al, (2023), The Lancet Regional Health - Europe, 29, 100635 - 100635
Estimating Uncertainty in Neural Networks for Cardiac MRI Segmentation: A Benchmark Study.
Ng M. et al, (2023), IEEE transactions on bio-medical engineering, 70, 1955 - 1966
Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review.
Pan J. et al, (2023), European heart journal. Cardiovascular Imaging
Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy
Hermida U. et al, (2023), European Heart Journal - Cardiovascular Imaging, 24, 807 - 818
Retained Metabolic Flexibility of the Failing Human Heart
Watson WD. et al, (2023), Circulation
Editorial Expression of Concern: Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance.
Liu A. et al, (2023), Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 25
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study.
Finnigan LEM. et al, (2023), EClinicalMedicine, 59
Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement.
Vidula MK. et al, (2023), JACC. Cardiovascular imaging, 16, 609 - 624
Prediction of incident cardiovascular events using machine learning and CMR radiomics.
Pujadas ER. et al, (2023), European radiology, 33, 3488 - 3500